Press release provided by Washington Research Foundation Washington Research Foundation (WRF) has awarded $250,000 to enable Physiology and Biophysics Professor Andrés Barría, Ph.D., to screen for new compounds that could be further developed for the treatment of neurological disorders and synaptopathies including Alzheimer’s disease and schizophrenia. Barría used a previous grant of $50,000 from WRF in 2021 to develop high-throughput screening assays that will be used in this work. NMDA-type glutamate receptors containing GluN2B subunits regulate many processes important to…
Andrés Barría receives grant from Washington Research Foundation to support research of Alzheimer’s and other disorders
